arXiv · 2004.08491
Is the anti-filarial drug diethylcarbamazine useful to treat COVID-19?
Abstract
The SARS-CoV-2 virus has resulted in a devastating pandemic of COVID-19. Exploring compounds that could offer a breakthrough in treatment is the need of the hour. Re-positioning cheap, freely available and safe drugs is a priority. The paper proposes evidence for the potential use of diethylcarbamazine (DEC) in the treatment of COVID-19. DEC has inhibitory effects on arachidonic acid metabolism to prostaglandins, little known anti-viral effects on animal retroviruses and demonstrated anti-inflammatory actions in animal models of lung inflammation indicating the need to explore this hypothesis further. We believe this is the first time DEC is being proposed to treat COVID-19.
Explore related subjects
Keep this discovery
Anuruddha Abeygunasekera, Saroj Jayasinghe. 2020-04-18. Is the anti-filarial drug diethylcarbamazine useful to treat COVID-19?. https://arxiv.org/abs/2004.08491
Cite the original work for its findings. Save a collection to share your selection of sources.